Hôpital Privé du Confluent

Nantes, Pays de la Loire Region 44277

0 studies enrolling now · 3 studies all time

What they study most

Adjuvant, EGFR, Early Stage Lung Cancer, Exon 20, Lung Cancer, NSCLC, Stage IB-IIIA, Pain, Post-surgical, Relapsed/Refractory Chronic Lymphocytic Leukemia, Richter's Syndrome, Small Lymphocytic Lymphoma, Treatment-naïve High Risk Chronic Lymphocytic Leukemia

Studies at this site

• Safety and Efficacy Study of Epcoritamab in Subjects With Relapsed/Refractory Chronic Lymphocytic Leukemia and Richter's Syndrome — Running, not enrolling
• A Study to Assess the Efficacy and Safety of Zipalertinib Versus Placebo for Adjuvant Treatment in Participants With Stage IB-IIIA NSCLC With Uncommon EGFR Mutations, Following Complete Tumor Resection — Running, not enrolling
• Real-World Outcomes Study on Subjects Treated With Radiofrequency Ablation — Completed